A Roadmap to CMC Planning in Inhaled Combination Product Development 

Creating inhaled combination products (ICPs) demands precision at the intersection of drug formulation and device engineering. These products deliver multiple active pharmaceutical ingredients (APIs) via a single device, making Chemistry, Manufacturing, and Controls (CMC) critical to ensuring safety, efficacy, and reliable drug delivery. 

This guide highlights essential CMC considerations, including formulation strategies, device compatibility, and analytical testing. Gain the insights needed to navigate ICP complexities, meet global regulatory standards, and ensure effective drug delivery to the lungs.